Anna Mowry Biography and Net Worth

Anna is an experienced finance and business leader who joins Nautilus from Igneous where she served as VP of Finance and Operations with responsibility for finance, accounting, people, legal, and operations. Previously, Anna held a variety of roles at companies including Amazon Web Services and Isilon Systems, where she ultimately led the finance and sales operations organization. Anna has a BS in Biochemistry from Western Washington University and started her career at the Fred Hutchinson Cancer Research Institute. She earned her MBA from the University of Washington, leading her into a variety of finance and business roles of escalating responsibility.

What is Anna Mowry's net worth?: The estimated net worth of Anna Mowry is at least $137,335.00 as of August 19th, 2022. Ms. Mowry owns 56,750 shares of Nautilus Biotechnology stock worth more than $137,335 as of April 23rd. This net worth evaluation does not reflect any other investments that Ms. Mowry may own. Additionally, Ms. Mowry receives an annual salary of $519,210.00 as CFO at Nautilus Biotechnology. Learn More about Anna Mowry's net worth.
How old is Anna Mowry?: Ms. Mowry is currently 40 years old. There are 6 older executives and no younger executives at Nautilus Biotechnology. The oldest executive at Nautilus Biotechnology is Ms. Gwen E. Weld, Chief People Officer, who is 66 years old. Learn More on Anna Mowry's age.
What is Anna Mowry's salary?: As the CFO of Nautilus Biotechnology, Inc., Ms. Mowry earns $519,210.00 per year. There are 2 executives that earn more than Ms. Mowry. The highest earning executive at Nautilus Biotechnology is Mr. Sujal M. Patel, Co-Founder, CEO, President, Secretary & Director, who commands a salary of $827,240.00 per year. Learn More on Anna Mowry's salary.
How do I contact Anna Mowry?: The corporate mailing address for Ms. Mowry and other Nautilus Biotechnology executives is 51 ASTOR PLACE 10TH FLOOR, NEW YORK NY, 10003. Nautilus Biotechnology can also be reached via phone at 206-333-2001 and via email at [email protected]. Learn More on Anna Mowry's contact information.
Has Anna Mowry been buying or selling shares of Nautilus Biotechnology?: Anna Mowry has not been actively trading shares of Nautilus Biotechnology during the past quarter. Most recently, on Friday, August 19th, Anna Mowry bought 17,500 shares of Nautilus Biotechnology stock. The stock was acquired at an average cost of $2.30 per share, with a total value of $40,250.00. Following the completion of the transaction, the chief financial officer now directly owns 56,750 shares of the company's stock, valued at $130,525. Learn More on Anna Mowry's trading history.
Who are Nautilus Biotechnology's active insiders?: Nautilus Biotechnology's insider roster includes Matthew Mcilwain (Director), Anna Mowry (CFO), Matthew Murphy (General Counsel), Sujal Patel (CEO), and Matthew Posard (Director). Learn More on Nautilus Biotechnology's active insiders.
Are insiders buying or selling shares of Nautilus Biotechnology?: In the last year, Nautilus Biotechnology insiders bought shares 3 times. They purchased a total of 38,303 shares worth more than $108,316.27. The most recent insider tranaction occured on March, 11th when CEO Sujal M Patel bought 12,044 shares worth more than $34,204.96. Insiders at Nautilus Biotechnology own 42.5% of the company. Learn More about insider trades at Nautilus Biotechnology.
Information on this page was last updated on 3/11/2024.

Anna Mowry Insider Trading History at Nautilus Biotechnology

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/19/2022	Buy	17,500	$2.30	$40,250.00	56,750
6/27/2022	Buy	5,500	$2.75	$15,125.00	39,250
8/12/2021	Buy	17,500	$7.71	$134,925.00

Anna Mowry Buying and Selling Activity at Nautilus Biotechnology

Nautilus Biotechnology Company Overview

Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. The company develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. It also offers proteome analysis system, a high-resolution optical imaging system for integrated fluidics and liquid handling sub-system. In addition, the company provides sample preparation, flow cells, multi-affinity probe reagents, and instrument buffers system to perform multi-cycle analysis runs. Nautilus Biotechnology, Inc. was incorporated in 2016 and is headquartered in Seattle, Washington.

Today's Range

Now: $2.42

$2.40

$2.49

50 Day Range

MA: $2.69

$2.34

$3.06

2 Week Range

Now: $2.42

$2.16

$4.65

Volume

31,663 shs

Average Volume

64,633 shs

Market Capitalization

$302.74 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.2

Global crypto currency reset (41 major banks signed up)

From Stansberry Research | Ad

Behind closed doors, at least 41 major US banks have signed up to a strange new crypto project...

Here's everything you need to know.

Anna Mowry Biography and Net Worth

What is Anna Mowry's net worth?

How old is Anna Mowry?

What is Anna Mowry's salary?

How do I contact Anna Mowry?

Has Anna Mowry been buying or selling shares of Nautilus Biotechnology?

Who are Nautilus Biotechnology's active insiders?

Are insiders buying or selling shares of Nautilus Biotechnology?